RxDoctor Payments Data

Alexis Furze, MD

Otolaryngology/Facial Plastic Surgery · Newport Beach, CANPI 1447453048

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (42.3%), other and travel and lodging — rather than concentrated in one kind of arrangement. 21 manufacturers reported payments, led by Kls-martin L.p. at 30.5% of the total. Reporting peaked in 2021 at $4,050 and has fallen 84.3% since, to $637 in 2025. Among otolaryngology/facial plastic surgery clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$12,060in general payments, 2019–2025

Across 154 payments — averaging $78.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Kls-martin L.p.$4K
  • Stryker$2K
  • Medical Device Business Services, Inc.$1K
  • Aerin Medical Inc.$1K
  • Intersect ENT, Inc.$1K
  • Optinose US, Inc.$1K
  • plus $2K from 15 others
$3,850in research payments, 2019–2025

Across 2 payments — averaging $1925.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Aerin Medical Inc.$4K

What the payments were for

  • Consulting fees$1,50012%
  • Travel & lodging$1,90716%
  • Food & beverage$5,09742%
  • Other$3,55529%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$12,060 in reported general payments places this provider in the 95th percentile of 102 otolaryngology/facial plastic surgery providers in California.

See all otolaryngology/facial plastic surgery providers in California

Medicare billing

Part B allowed, 2024
$244,292
Medicare patients
97
Services billed
632

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ipratropium Bromide49$1,655
Doxycycline Hyclate16$120

Paid to pharmacies, not to this prescriber.

Other otolaryngology/facial plastic surgery in Newport Beach

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →